REYOBIQ

Houston, Texas, August 14, 2026 Cerenome, Inc. reported continued progress across its integrated central nervous system (CNS) oncology platform,...

Houston, Texas, USA | July 21, 2026 Plus Therapeutics, through its wholly owned subsidiary CNSide Diagnostics, announced a regional...

HOUSTON & LAKE FOREST, Calif., July 16, 2026 Plus Therapeutics and Genomic Testing Cooperative (GTC) announced a strategic collaboration...